Department of Gynecology, Xiangya Hospital, Central South University, Changsha, China.
Gynecological Oncology Research and Engineering Center of Hunan Province, Changsha, China.
Int J Gynaecol Obstet. 2022 Jan;156(1):159-165. doi: 10.1002/ijgo.13683. Epub 2021 Apr 13.
To explore treatment strategies for patients with positive margins after cervical cold knife conization (CKC) by estimating the risk of residual or recurrent CIN2 or worse (CIN2+).
A retrospective study included 569 patients receiving CKC for CIN3 in Xiangya Hospital from January 2013 to December 2017. Demographic characteristics and test results were obtained before CKC, after CKC, at 6, 12, and 24 months, then annually thereafter. The primary end point was residual/recurrent CIN2+ post-CKC.
Fourteen (2.46%) patients had residual/recurrent CIN2+ with a median time of occurrence at 12 months post-CKC. Taking the average age and hrHPV viral load tested by Hybrid Capture 2 (HC2) as thresholds, the risk of residual/recurrent CIN2+ was higher in women aged over 40 years or with a baseline HC2 of 300 or more for the ratio of relative light units to positive cut-off values. Patients with positive margins were at higher risk of residual/recurrent CIN2+ (hazard ratio 3.66, 95% confidence interval 1.25-10.71), especially when endocervix was involved. A total of 536 (94.20%) patients received HPV testing within 6 months after CKC. Patients with both positive HPV testing results and positive margins were at the highest risk of residual/recurrent CIN2+.
Patients with positive endocervical margins are at high risk for residual/recurrent CIN2+, independent of the severity of margins. HPV testing within 6 months after CKC may be a feasible triage strategy for these patients.
通过评估宫颈冷刀锥切术(CKC)后切缘阳性患者发生残留或复发 CIN2 或更高级别病变(CIN2+)的风险,探讨其治疗策略。
回顾性研究纳入 2013 年 1 月至 2017 年 12 月在湘雅医院接受 CKC 治疗的 569 例 CIN3 患者。在 CKC 前、后及 6、12、24 个月和此后每年获取患者的人口统计学特征和检查结果。主要终点为 CKC 后残留/复发 CIN2+。
14 例(2.46%)患者发生残留/复发 CIN2+,中位发生时间为 CKC 后 12 个月。以平均年龄和杂交捕获 2(HC2)检测的 HRHPV 病毒载量为界值,年龄>40 岁或基线 HC2 载量为 300 或更高的患者,其发生残留/复发 CIN2+的风险更高。切缘阳性患者发生残留/复发 CIN2+的风险更高(风险比 3.66,95%置信区间 1.25-10.71),尤其是累及宫颈管时。共有 536 例(94.20%)患者在 CKC 后 6 个月内接受 HPV 检测。HPV 检测结果和切缘均阳性的患者发生残留/复发 CIN2+的风险最高。
切缘阳性的患者有发生残留/复发 CIN2+的高风险,且与切缘严重程度无关。CKC 后 6 个月内进行 HPV 检测可能是这类患者的可行筛查策略。